Get Quote

Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Game Rating: 1 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recs

0
Member Avatar WRXkid (62.05) Submitted: 29/03/2012 14:01:49 : Outperform Start Price: $4.83 KERX Score: +47.73

Possible positive outcome of clinical trials for perifosine.

Report this Post Reply

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.